Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors

医学 主旨 随机化 内科学 临床终点 甲磺酸伊马替尼 伊马替尼 人口 临床试验 随机对照试验 队列研究 佐剂 队列 外科 间质细胞 环境卫生 髓系白血病
作者
Heikki Joensuu,Mikael Eriksson,Kirsten Sundby Hall,Annette Reichardt,Bárbara Hermes,J. Schütte,Silke Cameron,Peter Hohenberger,Philipp J. Jost,Salah‐Eddin Al‐Batran,Lars H. Lindner,Sebastian Bauer,Eva Wardelmann,Bengt Nilsson,Raija Kallio,Panu Jaakkola,Jouni Junnila,Thor Alvegård,Peter Reichardt
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:6 (8): 1241-1241 被引量:150
标识
DOI:10.1001/jamaoncol.2020.2091
摘要

Importance

Adjuvant imatinib is associated with improved recurrence-free survival (RFS) when administered after surgery to patients with operable gastrointestinal stromal tumor (GIST), but its influence on overall survival (OS) has remained uncertain.

Objective

To evaluate the effect of adjuvant imatinib on OS of patients who have a high estimated risk for GIST recurrence after macroscopically complete surgery.

Design, Setting, and Participants

In this open-label, randomized (1:1), multicenter phase 3 clinical trial conducted in Finland, Germany, Norway, and Sweden, 400 patients who had undergone macroscopically complete surgery for GIST with a high estimated risk for recurrence according to the modified National Institutes of Health Consensus Criteria were enrolled between February 2004 and September 2008. Data for this follow-up analysis were analyzed from September to November, 2019.

Interventions

Imatinib 400 mg/d administered orally for either 12 months or 36 months after surgery.

Main Outcomes And Measures

The primary end point was RFS; the secondary objectives included OS and treatment safety.

Results

The intention-to-treat cohort consisted of 397 patients (12-month group, 199; 36-month group, 198; 201 men and 196 women; median [IQR] age, 62 (51-69) years and 60 (51-67) years, during a median follow-up time of 119 months after the date of randomization, 194 RFS events and 96 OS events were recorded in the intention-to-treat population. Five-year and 10-year RFS was 71.4% and 52.5%, respectively, in the 36-month group and 53.0% and 41.8% in the 12-month group (hazard ratio [HR], 0.66; 95% CI, 0.49-0.87;P = .003). In the 36-month group, 5-year OS and 10-year OS rates were 92.0% and 79.0%, respectively, and in the 12-month group 85.5% and 65.3% (HR, 0.55; 95% CI, 0.37-0.83;P = .004). The results were similar in the efficacy population, from which 15 patients who did not have GIST in central pathology review and 24 patients who had intra-abdominal metastases removed at surgery were excluded (36-month group, 10-year OS 81.6%; 12-month group, 66.8%; HR, 0.50; 95% CI, 0.32-0.80;P = .003). No new safety signals were detected.

Conclusions and Relevance

Three years of adjuvant imatinib is superior in efficacy compared with 1 year of imatinib. Approximately 50% of deaths may be avoided during the first 10 years of follow-up after surgery with longer adjuvant imatinib treatment.

Trial Registration

ClinicalTrials.gov Identifier:NCT00116935
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
抹不掉的记忆完成签到,获得积分10
刚刚
刚刚
余杭村王小虎完成签到,获得积分10
1秒前
韭黄完成签到,获得积分20
5秒前
jeffrey完成签到,获得积分10
5秒前
Rondab应助机灵枕头采纳,获得10
11秒前
佳无夜完成签到,获得积分10
16秒前
摆哥完成签到,获得积分10
20秒前
66完成签到,获得积分10
25秒前
zlqq完成签到 ,获得积分10
25秒前
Hardskills发布了新的文献求助10
28秒前
29秒前
之_ZH完成签到 ,获得积分10
37秒前
gds2021完成签到 ,获得积分10
39秒前
你好呀嘻嘻完成签到 ,获得积分10
39秒前
梅特卡夫完成签到,获得积分10
41秒前
熊雅完成签到,获得积分10
42秒前
44秒前
睡到自然醒完成签到 ,获得积分10
45秒前
cis2014完成签到,获得积分10
47秒前
独特的大有完成签到 ,获得积分10
47秒前
量子星尘发布了新的文献求助10
48秒前
50秒前
xingyi完成签到,获得积分10
52秒前
53秒前
舒心的秋荷完成签到 ,获得积分10
56秒前
zz123发布了新的文献求助10
57秒前
liaomr完成签到 ,获得积分10
57秒前
粗犷的灵松完成签到,获得积分10
58秒前
吃小孩的妖怪完成签到 ,获得积分10
58秒前
ncuwzq完成签到,获得积分10
1分钟前
yshj完成签到 ,获得积分10
1分钟前
1分钟前
净禅完成签到 ,获得积分10
1分钟前
1分钟前
迷人的寒风完成签到,获得积分10
1分钟前
1分钟前
water应助科研通管家采纳,获得10
1分钟前
Lucas应助HHHAN采纳,获得10
1分钟前
无情修杰完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022